RPC
MRK icon

Rossmore Private Capital’s Merck MRK Stock Holding History

Rossmore Private Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,000
Closed -$105K – 358
2025
Q4 		$105K Buy
+1,000
New +$93.9K 0.01% 303

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Rossmore Private Capital's MRK Position: Q2 2026 in Review

Rossmore Private Capital reduced its Merck (MRK) stake by 0.52% in Q2 2026, selling an estimated $35.1K and leaving 57,121 shares worth $7.39M. The position accounts for 0.6% of the portfolio, ranked #39.

Rossmore Private Capital first reported a position in MRK in Q4 2017 and has held it in 33 quarters since. The position peaked at $9.66M in Q1 2024. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Rossmore Private Capital held 57,121 shares of Merck worth $7.39M as of Q2 2026.
  • Rossmore Private Capital sold 300 Merck shares in Q2 2026, an estimated $35.1K.
  • Merck made up 0.6% of Rossmore Private Capital's portfolio in Q2 2026, its #39 holding.
  • Rossmore Private Capital first reported a position in Merck in Q4 2017 and has held it in 33 quarters since.
  • Rossmore Private Capital's Merck position peaked at $9.66M in Q1 2024.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Rossmore Private Capital's 13F filing for Q2 2026, filed 31 Jul 2026.